4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-030014
EVP, Drug Development sold 1,529 shares at $17.66 ($27,009)
- EVP, Drug Development acquired 1,529 shares (other)
From the SEC's structured data for this filing
Trades in this filing
MANHARD KIMBERLY · EVP, Drug Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-30 | Other acquisition : show line 1 in the form | +1,529 | $13.90 | $21,249 | 3,163 | D |
| 2021-05-03 | Sale : show line 2 in the form | −1,529 | $17.66 | $27,009 | 1,634 | D |
| Open-market sales · 1,529 sh · avg $17.66 · $27,009 | ||||||
Loading xslF345X03/doc4.xml…